Mark A. Schroeder, MD, discusses the importance of JAK inhibition in graft-versus-host disease (GVHD).
Mark A. Schroeder, MD
Advertisement
Articles by Mark A. Schroeder, MD
Mark A. Schroeder, MD, discusses therapies currently available and being investigated to treat patients with graft-versus-host disease.
Advertisement
Latest Updated Articles
Dr. Schroeder on Treatment Options for GVHDFebruary 28th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5